ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 45 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,097,716 | -7.1% | 185,425 | +16.4% | 0.00% | – |
| Q2 2023 | $1,181,628 | -68.6% | 159,249 | -60.0% | 0.00% | – |
| Q1 2023 | $3,761,837 | +45.0% | 398,078 | +63.4% | 0.00% | – |
| Q4 2022 | $2,593,839 | +108.8% | 243,553 | +44.8% | 0.00% | – |
| Q3 2022 | $1,242,000 | -14.9% | 168,237 | -44.6% | 0.00% | – |
| Q2 2022 | $1,460,000 | +82.3% | 303,765 | +93.6% | 0.00% | – |
| Q1 2022 | $801,000 | -50.0% | 156,865 | -41.2% | 0.00% | – |
| Q4 2021 | $1,602,000 | -32.8% | 266,600 | -1.0% | 0.00% | – |
| Q3 2021 | $2,385,000 | +150.0% | 269,200 | +123.0% | 0.00% | – |
| Q2 2021 | $954,000 | +13.7% | 120,733 | +9.7% | 0.00% | – |
| Q1 2021 | $839,000 | -61.0% | 110,055 | -60.1% | 0.00% | – |
| Q4 2020 | $2,150,000 | +402.3% | 275,682 | +524.7% | 0.00% | – |
| Q3 2020 | $428,000 | – | 44,131 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corton Capital Inc. | 13,966 | $103,000 | 0.13% |
| Delphia (USA) Inc. | 14,226 | $105,000 | 0.12% |
| Sentinus, LLC | 22,500 | $166,000 | 0.10% |
| Intrepid Financial Planning Group LLC | 20,000 | $148,000 | 0.08% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $89,000 | 0.06% |
| J. Goldman & Co LP | 148,738 | $1,098,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 88,966 | $657,000 | 0.02% |
| EMFO, LLC | 1,666 | $12,000 | 0.01% |
| Virtu Financial LLC | 12,590 | $93,000 | 0.01% |
| Jump Financial, LLC | 23,400 | $173,000 | 0.01% |